991 related articles for article (PubMed ID: 7874668)
1. Clinical relationship of extrapyramidal symptoms and tardive dyskinesia.
Andrew HG
Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S76-80. PubMed ID: 7874668
[TBL] [Abstract][Full Text] [Related]
2. Incidence of extrapyramidal symptoms and tardive dyskinesia in schizophrenia: thirty-six-month results from the European schizophrenia outpatient health outcomes study.
Novick D; Haro JM; Bertsch J; Haddad PM
J Clin Psychopharmacol; 2010 Oct; 30(5):531-40. PubMed ID: 20814320
[TBL] [Abstract][Full Text] [Related]
3. Evolution of neuroleptic-induced extrapyramidal syndromes under long-term neuroleptic treatment.
Modestin J; Wehrli MV; Stephan PL; Agarwalla P
Schizophr Res; 2008 Mar; 100(1-3):97-107. PubMed ID: 18055180
[TBL] [Abstract][Full Text] [Related]
4. Neuroleptic drug-induced extrapyramidal syndromes and tardive dyskinesia.
Casey DE
Schizophr Res; 1991; 4(2):109-20. PubMed ID: 1674881
[TBL] [Abstract][Full Text] [Related]
5. [Recent research trends in diagnosis, treatment, and prevention of drug-induced extrapyramidal symptoms seen in psychiatric patients].
Inada T
Nihon Shinkei Seishin Yakurigaku Zasshi; 1996 Oct; 16(5):181-5. PubMed ID: 8962437
[TBL] [Abstract][Full Text] [Related]
6. Movement disorders associated with neuroleptic treatment.
Wirshing WC
J Clin Psychiatry; 2001; 62 Suppl 21():15-8. PubMed ID: 11584982
[TBL] [Abstract][Full Text] [Related]
7. Motor and mental side effects of clozapine.
Gerlach J; Peacock L
J Clin Psychiatry; 1994 Sep; 55 Suppl B():107-9. PubMed ID: 7961551
[TBL] [Abstract][Full Text] [Related]
8. Novel antipsychotics, extrapyramidal side effects and tardive dyskinesia.
Barnes TR; McPhillips MA
Int Clin Psychopharmacol; 1998 Mar; 13 Suppl 3():S49-57. PubMed ID: 9690971
[TBL] [Abstract][Full Text] [Related]
9. Clozapine-induced tardive dyskinesia in schizophrenic patients taking clozapine as a first-line antipsychotic drug.
Li CR; Chung YC; Park TW; Yang JC; Kim KW; Lee KH; Hwang IK
World J Biol Psychiatry; 2009; 10(4 Pt 3):919-24. PubMed ID: 19995222
[TBL] [Abstract][Full Text] [Related]
10. Extrapyramidal syndromes and new antipsychotic drugs: findings in patients and non-human primate models.
Casey DE
Br J Psychiatry Suppl; 1996 May; (29):32-9. PubMed ID: 8733821
[No Abstract] [Full Text] [Related]
11. Clozapine treatment of psychosis in patients with tardive dystonia: report of three cases.
Friedman JH
Mov Disord; 1994 May; 9(3):321-4. PubMed ID: 7913739
[TBL] [Abstract][Full Text] [Related]
12. Neuroleptic-induced acute extrapyramidal syndromes and tardive dyskinesia.
Casey DE
Psychiatr Clin North Am; 1993 Sep; 16(3):589-610. PubMed ID: 8105453
[TBL] [Abstract][Full Text] [Related]
13. Drug-induced parkinsonism: relationship to age at onset of schizophrenia.
Sandyk R; Kay SR
Funct Neurol; 1991; 6(2):151-7. PubMed ID: 1680777
[TBL] [Abstract][Full Text] [Related]
14. Clozapine treatment for neuroleptic-induced tardive dyskinesia, parkinsonism, and chronic akathisia in schizophrenic patients.
Spivak B; Mester R; Abesgaus J; Wittenberg N; Adlersberg S; Gonen N; Weizman A
J Clin Psychiatry; 1997 Jul; 58(7):318-22. PubMed ID: 9269253
[TBL] [Abstract][Full Text] [Related]
15. Movement disorders with neuroleptic drug treatment.
Tarsy D
Psychiatr Clin North Am; 1984 Sep; 7(3):453-71. PubMed ID: 6148742
[TBL] [Abstract][Full Text] [Related]
16. The problem of tardive akathisia.
Gualtieri CT
Brain Cogn; 1993 Sep; 23(1):102-9. PubMed ID: 8105819
[TBL] [Abstract][Full Text] [Related]
17. Metric characteristics of the drug-induced extrapyramidal symptoms scale (DIEPSS): a practical combined rating scale for drug-induced movement disorders.
Kim JH; Jung HY; Kang UG; Jeong SH; Ahn YM; Byun HJ; Ha KS; Kim YS
Mov Disord; 2002 Nov; 17(6):1354-9. PubMed ID: 12465082
[TBL] [Abstract][Full Text] [Related]
18. Incidence and persistence of tardive dyskinesia and extrapyramidal symptoms in schizophrenia.
Tenback DE; van Harten PN; Slooff CJ; van Os J
J Psychopharmacol; 2010 Jul; 24(7):1031-5. PubMed ID: 19487321
[TBL] [Abstract][Full Text] [Related]
19. [Current data on neurologic sequelae caused by neuroleptics].
Krebs MO
Encephale; 1995 Jun; 21 Spec No 3():49-52. PubMed ID: 7628342
[TBL] [Abstract][Full Text] [Related]
20. [New chemotherapy approaches to psychoses].
Olié JP; Baylé FJ
Encephale; 1997 Apr; 23 Spec No 2():2-9. PubMed ID: 9273302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
